A clinical viewpoint on the EASO grade-based pharmacological algorithm for obesity management

• by Andreea Ciudin, Borja Martinez-Tellez, Barbara McGowan

• October 8, 2025

NLR inflammasome pathways: key targets for pathogenesis and therapy of metabolic diseases

• by Jun Zhou, Ruohao Yang, Wanyu Zhu, Zhilin He, Yueke Ma, Zhiwei Feng, Lili Yu

• May 29, 2026

Optimal Dietary Patterns for Lower Weight Gain and Risk of Obesity Surrounding Menopause

• by Tong Xia, Danielle E. Haslam, A. Heather Eliassen, JoAnn E. Manson, Qi Sun, Walter C. Willett, Shilpa N. Bhupathiraju, Cuilin Zhang, Frank B. Hu

• May 20, 2026

Combination Therapy Shows Potential in Psoriasis, Obesity

Researchers assess whether adding tirzepatide to ixekizumab affects skin and weight outcomes in adults with moderate to severe plaque psoriasis.

• by Kathryn Wighton

• May 20, 2026

• 5 min